AwarenessCTF in the NewsFeaturedFeatured EU CTF Rings The Opening Bell® at the New York Stock Exchange
Collaborations & PartnershipsFeaturedFeatured EUPress ReleaseScience & ResearchSWN Revolutionary Partnership Drives Breakthrough Research Investigation into Schwannomatosis
CTF in the NewsFeaturedFeatured EU Real Clear Publishes Thought Piece from CTF CEO Annette Bakker about Using Federal Funding in Research
AdvocacyFeaturedFeatured EUPress ReleaseTop Story EU Moving ahead in the European Union’s Pharmaceutical Debate
Collaborations & PartnershipsFeaturedFeatured EUGlobalNF1Press Release Healx to receive investment from Children’s Tumor Foundation to advance Neurofibromatosis Type 1 treatments
FeaturedFeatured EUGlobalScience & Research Young Investigator: Q&A with Clara Nogué about schwannomatosis cell lines
FeaturedFeatured EUNF RegistryNF1 CTF-Funded Research Sheds Light on Experiences of Chronic Pain in NF1
FeaturedFeatured EUNF1Science & Research CTF-Funded Study Utilizes Promising Blood Test for Predicting Cancer Risk in NF Patients
